MAX汽車工業每日三倍做空ETN CARD 深 滬
等待開盤 10-28 09:30:00 美东时间
2.73
-0.260
-8.70%
華盛通- 最 高2.89
- 今 開2.89
- 成交量 1.55万股
- 最 低 2.73
- 昨 收 2.99
- 總市值 163.80万
- 52周最高 4.03
- 市盈率 靜 --
- 換手率 2.58%
- 52周最低 2.095
- 委 比 0.00%
- 總股本 60.00万
- 歷史最高 36.23
- 量 比 2.26
- 振 幅 5.35%
- 歷史最低 2.095
- 每 手 1
- 風險率 0.37%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多AstraZeneca PLC Stock (AZN) Moved Up by 3.04% on Oct 22: A Full Analysis
• FDA granted accelerated approval for Ultomiris to treat primary IgA nephropathy. • AstraZeneca reports annual revenue of $58.74B and net profit of $10.22B. • Analysts issued Buy ratings with an average price target of $210.32.
10-22 18:15
Metropal Kurumsal Hizmetler Denies Links to Liquidated Investment Funds
Metropal Kurumsal Hizmetler A.S. ( ($TR:MCARD) ) has shared an announcement. Me...
10-21 22:13
Indian Card Clothing appoints Tushar Vaidya as Non-Executive Director
The latest announcement is out from Indian Card Clothing Co. Ltd. ( ($IN:INDIAN...
10-21 05:23
Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences
Milestone Pharmaceuticals announced that data and updates for CARDAMYST® (etripamil) nasal spray will be presented at three upcoming cardiovascular meetings: the CAPP National Conference (October 22-24), TCT 2026 (October 31-November 3), and AHA Scientific Sessions 2026 (November 6-9). Presentations will cover PSVT treatment, Phase 3 trial design for atrial fibrillation, and etripamil's efficacy and safety. CARDAMYST is approved for acute PSVT ep...
10-19 12:00
SBI Cards Vests Over 187,000 Shares Under 2023 ESOP Plan
The latest update is out from SBI Cards & Payment Services Ltd ( ($IN:SBICA...
10-18 17:53
Metropal Kurumsal Hizmetler Launches Three‑Year Share Buy‑Back Program
Metropal Kurumsal Hizmetler A.S. ( ($TR:MCARD) ) has issued an announcement. Me...
10-17 00:48
EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe
Philips and the University Medical Center Groningen have launched the five-year EXIT-CVD project, co-funded by the European Union and industry partners, to transform cardiovascular disease detection, monitoring, and treatment. The project involves 42 partners across 17 countries, conducting 22 clinical studies with over 14,000 patients. It focuses on three key exit points: early detection, personalized interventions, and advanced therapies. The p...
10-15 08:00
Metropal Corrects Share Buy-Back Price in Ongoing Repurchase Program
Metropal Kurumsal Hizmetler A.S. ( ($TR:MCARD) ) just unveiled an update. Metro...
10-09 03:12
Metropal Kurumsal Hizmetler Secures KOSGEB Support for TEKMER Technology Center
Metropal Kurumsal Hizmetler A.S. ( ($TR:MCARD) ) just unveiled an update. Metro...
10-01 21:43
Card Factory Cancels Over 500,000 Shares After Latest Buyback Tranche
Card Factory ( ($GB:CARD) ) has issued an announcement. Card Factory has repurc...
09-28 14:20
